Static Magnetic Field Control of Microbial Growth for Biogas and Antibiotic Production
Research platform investigating how static magnetic fields influence anaerobic and aerobic microbial digestion. Aims to quantify magnetic strength effects on Archaea and bacteria to optimize biogas production and antibiotic manufacturing processes.
Overview
This research program investigates the effect of static magnetic fields (SMF) on microbial growth, with a focus on Archaea and bacteria involved in anaerobic and aerobic digestion. Microbes are central to many industrial and energy applications, including biogas production and antibiotic manufacturing (such as Vancomycin). The research team aims to quantify how varying magnetic field strengths influence microbial behavior, enabling new methods to control bio-growth in fermentation reactors and related bioprocesses.
The project builds on prior ground-based studies showing that specific magnetic field intensities (ranging from 2.5 to 25.6 mT) affect microbial growth differently. By understanding and controlling this phenomenon, the team seeks to unlock practical benefits for energy carriers, pharmaceutical production, and colony management.
Technical specifications
Key features:
- Magnetotactic bacteria (MTB) — microorganisms that orient and migrate along magnetic field lines using intracellular magnetosome organelles containing nanometer-sized magnetic iron mineral crystals
- Experimental magnetic field range — 2.5, 5.9, 11.4, 16.4, 20.4, and 25.6 mT applied during anaerobic and aerobic digestion
- Biomass measurement protocols to quantify growth responses
- 16S RNA and DNA sequencing pre- and post-experiment for culture characterization
- Microscopic observation using ultramicroscopy and Atomic Force Microscopy (AFM) for morphological change detection
- Protein analyses and mitochondria characterization to investigate underlying biological mechanisms
- All experiments conducted in triplicate for statistical robustness
Technology readiness level
This research is at an early investigative stage (TRL 2–3). Prior ground-based studies have established preliminary observations linking specific magnetic field strengths to altered microbial growth, but the underlying mechanism remains unknown. The proposed 16-month study will validate findings through systematic triplicate experiments, biomass quantification, genetic sequencing, and advanced microscopy. The team is seeking funding for staff and equipment to advance toward practical applications in biogas and antibiotic production.
About Columbia University
Columbia University is a comprehensive private research university in New York City, combining an Ivy League academic profile with globally engaged scholarship and professional education. Its integration with a major hospital system through Columbia University Irving Medical Center and NewYork-Presbyterian enables clinical collaboration, access to diverse patient populations, and regulated studies at scale. State-of-the-art laboratories and shared core facilities across the Morningside and Manhattanville campuses support co-located industry projects, while proximity to New York’s finance, media, and healthcare ecosystems streamlines talent pipelines and pilot deployments. Industry engages via sponsored research, affiliate programs, executive education, and convenings that connect faculty expertise with corporate R&D priorities. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DoD, alongside New York State and philanthropic sources. Columbia Technology Ventures provides IP management, licensing, startup support, and translational funding mechanisms that lower barriers to commercialization.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.